Good returns motivate pharma to develop new drugs

09/3/2013 | Investopedia

The public needs to know that high prices of drugs are directly tied to the high costs of developing safer treatments that allow them to live better and longer, Stephen D. Simpson writes. Given the high risks and huge amounts of capital involved in drug development, there is nothing wrong with drugmakers obtaining a good return, he writes.

View Full Article in:


Published in Brief: